Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Aug 7, 2026, 5:51 PM EST
Britannia Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 14.65 | 7.39 | -4.77 | 5.08 | -15.46 |
Depreciation & Amortization | 0.06 | 0.06 | -0.04 | 0.16 | 0.19 |
Other Amortization | - | - | 0.1 | 0.07 | 0 |
Loss (Gain) From Sale of Assets | -1.67 | -0.23 | -0.47 | -1.39 | - |
Loss (Gain) From Sale of Investments | -15.81 | - | - | - | - |
Loss (Gain) on Equity Investments | 1.91 | 2.09 | 0.96 | 0.02 | 0 |
Stock-Based Compensation | - | - | 0.23 | 1.05 | 1.11 |
Other Operating Activities | -0.31 | -11.94 | 2.55 | -2.57 | 16.5 |
Change in Accounts Receivable | -0.76 | -0.09 | 0.17 | 0.2 | -0.1 |
Change in Inventory | - | 0.18 | 0.07 | - | - |
Change in Accounts Payable | -1.07 | 0.99 | 0.3 | -0.65 | 0.62 |
Change in Income Taxes | 0.29 | - | - | - | - |
Change in Other Net Operating Assets | -0.02 | -0.01 | 0.01 | 0.04 | -0.05 |
Operating Cash Flow | -1.16 | -2.62 | 2.09 | 2.01 | 2.8 |
Operating Cash Flow Growth | - | - | 4.15% | -28.26% | - |
Capital Expenditures | - | - | - | -0.06 | -0.09 |
Cash Acquisitions | - | - | -1.1 | -2.98 | 0.74 |
Sale (Purchase) of Intangibles | - | - | - | -0.29 | - |
Investment in Securities | -5.25 | -2.01 | - | - | - |
Other Investing Activities | - | 12.33 | -0.34 | - | - |
Investing Cash Flow | -5.25 | 10.32 | -1.44 | -3.32 | 0.65 |
Short-Term Debt Issued | - | - | 0.03 | - | 0.12 |
Long-Term Debt Issued | - | 1.68 | - | 7.98 | 1.41 |
Total Debt Issued | - | 1.68 | 0.03 | 7.98 | 1.53 |
Short-Term Debt Repaid | -0.01 | -0.02 | - | -4.96 | -3.44 |
Long-Term Debt Repaid | -0.1 | -1.08 | -0.09 | -0.07 | -0.08 |
Total Debt Repaid | -0.11 | -1.1 | -0.09 | -5.03 | -3.52 |
Net Debt Issued (Repaid) | -0.11 | 0.58 | -0.06 | 2.95 | -1.99 |
Issuance of Common Stock | - | - | - | - | 0 |
Other Financing Activities | - | -1.79 | -1.91 | -0.79 | -0.6 |
Financing Cash Flow | -0.11 | -1.21 | -1.97 | 2.16 | -2.58 |
Foreign Exchange Rate Adjustments | -0.01 | 0.04 | 0.05 | 0.13 | -0.07 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | -6.52 | 6.53 | -1.28 | 0.97 | 0.8 |
Free Cash Flow | -1.16 | -2.62 | 2.09 | 1.95 | 2.71 |
Free Cash Flow Growth | - | - | 7.10% | -27.99% | - |
Free Cash Flow Margin | -243.50% | -709.38% | 404.71% | 30.50% | 37.16% |
Free Cash Flow Per Share | -0.01 | -0.02 | 0.01 | 0.01 | 0.03 |
Levered Free Cash Flow | -1.22 | -6.88 | 5.19 | 0.43 | 1.79 |
Unlevered Free Cash Flow | -1.21 | -6.82 | 5.25 | 0.96 | 3.24 |
Cash Interest Paid | - | - | - | 0.79 | - |
Change in Working Capital | -1.57 | 1.07 | 0.55 | -0.42 | 0.46 |